Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chandi Ratnatunga

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Circulation|August 31, 2006
5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase couplingCharalambos Antoniades, Cheerag Shirodaria, Nicholas Warrick, et al.
European Heart Journal|March 20, 2009
Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosisCharalambos Antoniades, Cheerag Shirodaria, Paul Leeson, et al.
Circulation|November 28, 2007
Altered plasma versus vascular biopterins in human atherosclerosis reveal relationships between endothelial nitric oxide synthase coupling, endothelial function, and inflammationCharalambos Antoniades, Cheerag Shirodaria, Mark Crabtree, et al.
Circulation|April 29, 2009
MTHFR 677 C>T Polymorphism reveals functional importance for 5-methyltetrahydrofolate, not homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosisCharalambos Antoniades, Cheerag Shirodaria, Paul Leeson, et al.
Circulation|April 11, 2007
Global improvement of vascular function and redox state with low-dose folic acid: implications for folate therapy in patients with coronary artery diseaseCheerag Shirodaria, Charalambos Antoniades, Justin Lee, et al.
Circulation|February 9, 2012
Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery diseaseColin Cunnington, Tim Van Assche, Cheerag Shirodaria, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Circulation|August 31, 2006
5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase couplingCharalambos Antoniades, Cheerag Shirodaria, Nicholas Warrick, et al.
European Heart Journal|March 20, 2009
Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosisCharalambos Antoniades, Cheerag Shirodaria, Paul Leeson, et al.
Circulation|November 28, 2007
Altered plasma versus vascular biopterins in human atherosclerosis reveal relationships between endothelial nitric oxide synthase coupling, endothelial function, and inflammationCharalambos Antoniades, Cheerag Shirodaria, Mark Crabtree, et al.
Circulation|April 29, 2009
MTHFR 677 C>T Polymorphism reveals functional importance for 5-methyltetrahydrofolate, not homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosisCharalambos Antoniades, Cheerag Shirodaria, Paul Leeson, et al.
Circulation|April 11, 2007
Global improvement of vascular function and redox state with low-dose folic acid: implications for folate therapy in patients with coronary artery diseaseCheerag Shirodaria, Charalambos Antoniades, Justin Lee, et al.
Circulation|February 9, 2012
Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery diseaseColin Cunnington, Tim Van Assche, Cheerag Shirodaria, et al.
Pageof 2